3 Promising Biotech Stocks for the Long-Term: August 2024

Some of the best biotech opportunities can be found in oversold obesity treatment stocks. Look at Eli Lilly (NYSE:LLY), for example.The last time I mentioned LLY, I said, “Oversold shares of Eli Lilly could easily bounce higher on sales of its obesity drugs. And it could easily jump higher with its Zepbound drug being considered for the treatment of sleep apnea.” That was on July 30, as the stock traded at about $780.Today, it’s already up to $893.04 and could easily push aggressively higher thanks to growi ...